155 related articles for article (PubMed ID: 36701777)
1. RETROPERITONEAL PERIVASCULAR EPITHELIOID CELL NEOPLASM (PECOMA) RESPONSE TO MTOR KINASE INHIBITION. A CASE REPORT WITH LITERATURE REVIEW.
Damirov F; Menge F; Hohenberger P
Georgian Med News; 2022 Nov; (332):56-59. PubMed ID: 36701777
[TBL] [Abstract][Full Text] [Related]
2. Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates.
Dickson MA; Schwartz GK; Antonescu CR; Kwiatkowski DJ; Malinowska IA
Int J Cancer; 2013 Apr; 132(7):1711-7. PubMed ID: 22927055
[TBL] [Abstract][Full Text] [Related]
3. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.
Wagner AJ; Malinowska-Kolodziej I; Morgan JA; Qin W; Fletcher CD; Vena N; Ligon AH; Antonescu CR; Ramaiya NH; Demetri GD; Kwiatkowski DJ; Maki RG
J Clin Oncol; 2010 Feb; 28(5):835-40. PubMed ID: 20048174
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with the mTOR inhibitor everolimus in a patient with perivascular epithelioid cell tumor.
Gennatas C; Michalaki V; Kairi PV; Kondi-Paphiti A; Voros D
World J Surg Oncol; 2012 Sep; 10():181. PubMed ID: 22943457
[TBL] [Abstract][Full Text] [Related]
5. A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report.
Meredith L; Chao T; Nevler A; Basu Mallick A; Singla RK; McCue PA; Bowne WB; Jiang W
Diagn Pathol; 2023 Apr; 18(1):45. PubMed ID: 37041531
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of retroperitoneal localized perivascular epithelioid cell tumor two years after initial diagnosis: case report.
Cihan YB; Kut E; Koç A
Sao Paulo Med J; 2019; 137(2):206-208. PubMed ID: 29340502
[TBL] [Abstract][Full Text] [Related]
7. TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review.
Purwar R; Soni K; Shukla M; Verma A; Kumar T; Pandey M
World J Surg Oncol; 2022 Mar; 20(1):62. PubMed ID: 35232443
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature.
Starbuck KD; Drake RD; Budd GT; Rose PG
Anticancer Res; 2016 Nov; 36(11):6161-6164. PubMed ID: 27793946
[TBL] [Abstract][Full Text] [Related]
9. Gynecologic perivascular epithelioid cell tumors (PEComas): a review of recent evidence.
Levin G; Capella MP; Meyer R; Brezinov Y; Gotlieb WH
Arch Gynecol Obstet; 2024 Jun; 309(6):2381-2386. PubMed ID: 38664269
[TBL] [Abstract][Full Text] [Related]
10. First pancreatic perivascular epithelioid cell tumor (PEComa) treated by mTOR inhibitor.
Gondran H; Thebaud E; Moreau A; Le Rhun M; Touchefeu Y; Regenet N; Musquer N
Pancreatology; 2019 Jun; 19(4):566-568. PubMed ID: 31130397
[TBL] [Abstract][Full Text] [Related]
11. Rare perivascular epithelial cell tumor of the colon 18F-FDG PET/CT imaging: A case report.
Chen Q; Wang P; Zhang X; Zhang J
Medicine (Baltimore); 2023 May; 102(20):e33802. PubMed ID: 37335716
[TBL] [Abstract][Full Text] [Related]
12. Transurethral en bloc resection of a bladder perivascular epithelioid cell tumor (PEComa): a case report.
Zeng SP; Sun YF; Ye JB; Zeng K; Li XB
BMC Urol; 2023 Mar; 23(1):28. PubMed ID: 36864398
[TBL] [Abstract][Full Text] [Related]
13. Effective Therapeutic Intervention and Comprehensive Genetic Analysis of mTOR Signaling in PEComa: A Case Report.
Weeber F; Koudijs MJ; Hoogstraat M; Besselink NJ; VAN Lieshout S; Nijman IJ; Cuppen E; Offerhaus GJ; Voest EE
Anticancer Res; 2015 Jun; 35(6):3399-403. PubMed ID: 26026101
[TBL] [Abstract][Full Text] [Related]
14. Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection.
Kirste S; Kayser G; Zipfel A; Grosu AL; Brunner T
Radiat Oncol; 2018 Feb; 13(1):28. PubMed ID: 29463266
[TBL] [Abstract][Full Text] [Related]
15. Primary perivascular epithelioid cell tumor (PEComa) in bone: A review of the literature and a case arising in the humerus with multiple metastases.
Zhong J; Hu Y; Si L; Xing Y; Geng J; Jiao Q; Zhang H; Yao W
J Bone Oncol; 2021 Feb; 26():100336. PubMed ID: 33240785
[TBL] [Abstract][Full Text] [Related]
16. Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas).
Sanfilippo R; Jones RL; Blay JY; Le Cesne A; Provenzano S; Antoniou G; Mir O; Fucà G; Fumagalli E; Bertulli R; Stacchiotti S; Brahmi M; Grosso F; Dufresne A; Hindi N; Sbaraglia M; Gronchi A; Collini P; Dei Tos AP; Casali PG
Clin Cancer Res; 2019 Sep; 25(17):5295-5300. PubMed ID: 31217199
[TBL] [Abstract][Full Text] [Related]
17. Dia-gnostic Challenges and Extraordinary Treatment Response in Rare Malignant PEComa Tumor of the Kidney.
Huľová S; Sycova-Mila Z; Macák D; Janega P; Chovanec M; Mardiak J; Mego M
Klin Onkol; 2018; 31(6):448-452. PubMed ID: 30545225
[TBL] [Abstract][Full Text] [Related]
18. Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors.
Sanfilippo R; Fabbroni C; Fucà G; Fumagalli E; Morosi C; Sbaraglia M; Gronchi A; Collini P; Dei Tos AP; Casali PG
Clin Cancer Res; 2020 Oct; 26(20):5534-5538. PubMed ID: 32605908
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18-FDG PET/CT in a patient with angiomyolipoma: Response to mammalian target of rapamycin inhibitor therapy.
Anwar H; Sachpekidis C; Schwarzbach M; Dimitrakopoulou-Strauss A
Hell J Nucl Med; 2017; 20(2):169-171. PubMed ID: 28697195
[TBL] [Abstract][Full Text] [Related]
20. Malignant perivascular epithelioid cell tumor in children: description of a case and review of the literature.
Alaggio R; Cecchetto G; Martignoni G; Bisogno G; Cheng L; Sperlì D; d'Amore ES; Dall'Igna P
J Pediatr Surg; 2012 Jun; 47(6):e31-40. PubMed ID: 22703822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
